AVXL
Anavex Life Sciences Corporation
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.65
+0.00 +0.00%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$4.66
+0.01 ▲ +0.22%
| Index | RUT | P/E | - | EPS (ttm) | -0.46 | Insider Own | 3.23% | Shs Outstand | 0.09B | Perf Week | - |
| Market Cap | 0.43B | Forward P/E | - | EPS next Y | 56.92% | Insider Trans | - | Shs Float | 0.09B | Perf Month | 19.85% |
| Enterprise Value | 0.30B | PEG | - | EPS next Q | -0.07 | Inst Own | 41.15% | Short Float | 22.71% | Perf Quarter | 13.97% |
| Income | -0.04B | P/S | - | EPS this Y | 39.81% | Inst Trans | 6.47% | Short Ratio | 13.21 | Perf Half Y | -51.46% |
| Sales | 0.00B | P/B | 3.4 | EPS next 5Y | - | ROA | -31.08% | Short Interest | 20.37M | Perf YTD | 30.62% |
| Book/sh | 1.37 | P/C | 3.27 | EPS past 3/5Y | 4.47% -3.79% | ROE | -33.63% | 52W High | -66.76% ($13.99) | Perf Year | -48.33% |
| Cash/sh | 1.42 | P/FCF | - | Sales past 3/5Y | - | ROIC | -31.55% | 52W Low | 62.59% ($2.86) | Perf 3Y | -50.53% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 15.81% | Gross Margin | - | Volatility(W/M) | 5.53% 5.97% | Perf 5Y | -66.86% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.28 | Perf 10Y | -8.64% |
| Dividend Ex-Date | - | Quick Ratio | 20.87 | EPS Q/Q | 55.32% | Profit Margin | - | RSI (14) | 54.83 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 20.87 | Sales Q/Q | - | SMA20 | 4.41% ($4.45) | Beta | 1.02 | Target Price | $22 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | 4.25% ($4.46) | Rel Volume | 0.64 | Prev Close | $4.65 |
| Employees | 34 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 51.34% - | SMA200 | -36.09% ($7.28) | Avg Volume(3M) | 1.54M | Price | $4.65 |
| IPO | 2006/8/2 | Option/Short | Yes/Yes | Trades | 7387 | Volume | 989,415 | Change | - |
뉴스 로딩 중...